NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/26/2022
Back to search
Official data from USPTO
PRECISION ADVANCE THE CELL & GENE THERAPY COLLECTIVE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
18
Latest update
07/26/2022
Trademark type
Combined
Nice classes
35, 41, 42
Filing date
03/03/2021
Registration date
07/26/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/26/2022
Last transaction
07/26/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
01/14/2021
First use in commerce
01/14/2021
Drawing code
3
Owner type
16
Owner location
Bethesda, MD, US
Examiner
DUBIN, DAVID I
Law office
L70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized gray word "PRECISION" stacked above the stylized green word "ADVANCE" that is followed by a green forward slash design, which is followed by the stylized black wording "THE CELL & GENE THERAPY COLLECTIVE". The stylized wording and design, as illustrated in the mark, are featured on top of a white rectangular background, which is not a claimed feature of the mark.
Holders and representatives
Holders
Precision Medicine Group, LLC
Representatives
Donna H. Hartman OLENDERFELDMAN LLP
Technical classification
Nice Classes
Class 35Class 41Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business management consulting services provided to pharmaceutical and life sciences companies to provide advice and business strategies to conduct and manage research and clinical development of targeted therapies and diagnosticsclinical solutionsregulatory guidancehealth economics designlaunch planningaccess strategypromotional effectivenessmarket adoption; business management consultation in the field of promotion opportunity assessmentpromotion effectivenesspayer promotion strategyaccount manager and sales force promotion strategy and distribution strategy; business management and business management consulting services in the fields of healthcarepharmaceuticalsbiotechnologymedical devicesfood and nutrition; public policy consulting services in the fields of healthcarepharmaceuticalsbiotechnologymedical devicesfood and nutrition; business consulting services provided to the healthcare industry in the nature of the creationcollectionanalysisreporting of data and information for support of business and public policy decision-making; provision of statistical and commercial and business information in the fields of healthcarepharmaceuticalsbiotechnologymedical deviceshealth insurancefood and nutrition
Class 41
Providing non-downloadable electronic publications in the nature of informational reports for support of business and policy decisions for the healthcare industry
Class 42
Scientific consulting services in the fields of healthcarepharmaceuticalsbiotechnologymedical devicesfood and nutrition; scientific consulting services for the health insurance industry; provision of scientific research information in the fields of healthcarepharmaceuticalsbiotechnologymedical deviceshealth insurancefood and nutrition; providing medical and scientific research information in the field of clinical trials as they relate to healthcarepharmaceuticalsbiotechnologymedical devicesfood and nutrition
Publications
History of USPTO decisions and trademark events.
18 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/26/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/10/2022
PUBO
PUBLISHED FOR OPPOSITION
05/10/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/20/2022
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/04/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/01/2022
CEPE
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
07/29/2021
ALIE
ASSIGNED TO LIE
07/29/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/26/2021
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
07/22/2021
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
07/22/2021
EPEN
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
07/22/2021
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
07/22/2021
DOCK
ASSIGNED TO EXAMINER
07/21/2021
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/04/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/03/2021
NWAP
NEW APPLICATION ENTERED
03/06/2021
Continuous trademark protection
Get notified about every new filing that threatens PRECISION ADVANCE THE CELL & GENE THERAPY COLLECTIVE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.